Vudalimab Biosimilar - Research Grade
Product Specifications
Background
Uses the same sequence as the therapeutic antibody Vudalimab
Specifications
Detects human PD-1 and human CTLA-4
Species Reactivity
Human
Target
PD-1 + CTLA-4
Applications
Functional Assays
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration
5mg/mL
Endotoxin
<1EU/mg Determined by LAL gel clotting assay
Purity
>90% by SDS-PAGE
Buffer
ICH3002
Shipping Conditions
Blue ice
Storage Conditions
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Formulation
20mM His/Asp, pH 5.0,Contains no stabilizers or preservatives
Applications Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GCAP1, CT (Guanylyl Cyclase-activating Protein 1, GCAP 1, Guanylate Cyclase Activator 1A, GUCA1A, C6orf131, GCAP, GCAP1, GUCA1)
GCAP1, CT (Guanylyl Cyclase-activating Protein 1, GCAP 1, Guanylate Cyclase Activator 1A, GUCA1A, C6orf131, GCAP, GCAP1, GUCA1)
